The device caused such an outrage in countries around the world that Bayer removed it from the market. However, despite thousands of reports of injury and tens of thousands of women lobbying to have it pulled from US shelves, Essure is still available in the United States.
Injuries continue to mount as a result. In the meantime, a plaintiff in a previous Essure injury case; Jessica Williams ...
continue reading...
Acknowledging a global decline in demand for its Essure contraceptive device, Bayer announced last week that it was pulling the device off the market around the world – except for the United States. In the same statement, the medical manufacturing giant sought to assure the public that the decision was “not linked to a safety or product quality problem.”
Tens of thousands of women in the ...
continue reading...
In 2011, the FDA approved a drug that many hoped would be the first step forward in blood thinning medication since Coumadin’s debut in the 1960s: Xarelto.
Created by Johnson & Johnson and Bayer, Xarelto has been responsible for over $3.2 billion in profits for its manufacturers and developers. It has also become Bayer’s top-selling medication ever. Yet despite its successes on paper, the reality is that more than 18,000 ...
continue reading...
A federal judge in Philadelphia has determined that an Essure lawsuit filed against pharmaceutical giant Bayer has enough merit to proceed. Bayer had previously moved for the case to be dismissed.
The judge sided with Bayer on most of its motion. The plaintiffs had originally brought 12 claims against the company and, using an FDA provision specific to devices granted premarket approval, Bayer argued that Essure was effectively protected from any ...
continue reading...
It’s been a little while since we’ve written about Mirena here on the Lopez McHugh blog. That doesn’t mean, however, that the problems with the device have subsided.
One of three hormonal IUDs available on the American contraception market, Mirena’s history of complications is long, and continues to grow. As it stands at the moment, thousands of lawsuits have been filed against against Bayer Healthcare for injuries suffered as a result ...
continue reading...Over 1,200 Xarelto lawsuits are pending in a multidistrict litigation in the U.S. District Court for the Eastern District of Louisiana. Xarelto plaintiffs allege that the anticoagulant drug’s manufacturers, including Bayer HealthCare Pharmaceuticals and Johnson & Johnson’s Janssen Pharmaceutical, did not provide patients and doctors with adequate warning about Xarelto’s severe bleeding risks.
Approved by the U.S. Food and Drug Administration (FDA) in ...
continue reading...
